IACS-010759 is a Complex I inhibitor and mediates apoptosis in AML dependent on OXPHOS; IACS-010759 in combination with radiotherapy sensitized the PD-1-resistant model to anti-PD-1 agents and prolonged survival time. Here, PDCD1 is linked to acute myeloid leukemia.